Beacon Crc: a Randomized, Phase 3 Study of Encorafenib (ENCO) and Cetuximab (CETUX) with or without Binimetinib (BiNI) vs. Choice of Either Irinotecan or Folfiri Plus Cetux in BRAF V600E-Mutant Metastatic Colorectal Cancer (mCRC) Arndt Vogel,Susanna Hegewisch-Becker,Gerald Prager, Gunnar Folprecht,Michael Stahl,Scott Kopetz,Axel Grothey, Eric van Cutsetn,Rona Yaeger,Harpreet Wasan,Takayuki Yoshino,Jayesh Desai,Fortunato Ciardello,Ashwin Gollerkeri,Kati Maharry,Fotios Loupakis,Y. Hong,Neeltje Steeghs,Tormod Kyrre Guren,Hendrik-Tobias Arkenau,Pilar Garcia-Alfons,Victor Sandor, Farina Christy-Bittel,Lisa Anderson,Josep TaberneroONCOLOGY RESEARCH AND TREATMENT(2020)引用 0|浏览2暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要